Kahneman and Tversky's prospect theory They postulate that individuals have loss aversion. What is loss aversion? It means that individuals experience ...

The good news: Drug shortages in 2023 have declined in the United States from their recent peak between 2010 and 2012. ...

The Congressional Budget Office (CBO) recently provided projections of U.S. health insurance levels between 2024 and ...

Why is it so difficult to estimate the value of orphan drugs indicated for the treatment of rare diseases? There are a ...

Delays in drug approval cost pharmaceutical companies money. These costs include both lost sales and the additional cost if clinical trials need to last ...

Recently, the Inflation Reduction Act (IRA) is receiving a lot of attention, particularly for its provision that allows CMS to begin price negotiations for ...

The above is the title of a useful manual of Kenney and Keast (2024). I summarize some key points below. Provide an overview of pharmacy contracts ...

The technology is amazing. Of The Economist: Fourteen years ago, Melanie Reid, a journalist, fell from a horse ...

See my previous posts on negotiating IRA prices in drug selection (Part 1) and sending manufacturer data (Part 2). Today we will talk about the ...

CMS launched Guidance on Negotiating IRA Prices last week. Below are some highlights on how medications will be selected. What medications are eligible ...